If you have been reading about reversed-phase HPLC and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-05-03. Numbers and descriptions here follow the published literature rather than marketing material.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or chemically modified byproducts. Mass spectrometry confirms the expected molecular mass and can indicate acetylation state or sequence errors. Amino acid analysis and peptide mapping supply complementary sequence-level information, while endotoxin testing is relevant for preparations intended for cell or animal work. Purity figures reported by suppliers refer to the method used and are not directly comparable across laboratories unless conditions are stated.
Lyophilized material is typically treated as a hygroscopic solid that should be brought to room temperature before the container is opened, which limits condensation on the powder. Reconstitution is commonly done with sterile water or a buffered diluent, and gentle mixing is preferred over vigorous agitation to reduce foaming and surface adsorption. Because peptides can bind to plastic and glass, diluents containing a small amount of carrier protein are sometimes used in laboratory work. Working solutions are generally aliquoted and prepared fresh rather than subjected to repeated freezing and thawing.
| Property | Value | Notes |
|---|---|---|
| First described | 1977 | Reported as a component of thymosin fraction 5 |
| Sequence length | 28 amino acids | N-terminal residue is acetylated |
| Net charge at neutral pH | Negative | Reflects a high proportion of acidic residues |
| Principal studied uses | Chronic hepatitis B and vaccine adjuvant | Research uses outnumber approved indications |
| Regulatory status | Approved in a limited number of countries | Not approved in the United States or most of Europe |
The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
Thymosin alpha-1 is a synthetic peptide of 28 amino acid residues that corresponds to a naturally occurring fragment first isolated from thymus tissue. Its chain is acetylated at the amino terminus, a modification that shields the peptide from rapid cleavage by aminopeptidases. The molecule carries a net negative charge at physiological pH and dissolves freely in water. Researchers classify it as an immune-modulating agent rather than a classical hormone, because it acts on several cell types of both the innate and the adaptive immune system.
The clearance of a substance is the volume of plasma that contains the same amount of the substance as has been removed from the plasma per unit time. When referring to the function of the kidney, clearance is considered to be the amount of liquid filtered out of the blood that gets processed by the kidneys or the amount of blood cleaned per time because it has the units of a volumetric flow rate [ volume per unit time ]. However, it does not refer to a real value; "the kidney does not completely remove a substance from the total renal plasma flow." From a mass transfer perspective and physiologically, volumetric blood flow (to the dialysis machine and/or kidney) is only one of several factors that determine blood concentration and removal of a substance from the body. Other factors include the mass transfer coefficient, dialysate flow and dialysate recirculation flow for hemodialysis, and the glomerular filtration rate and the tubular reabsorption rate, for the kidney. A physiologic interpretation of clearance (at steady-state) is that clearance is a ratio of the mass generation and blood (or plasma) concentration. Its definition follows from the differential equation that describes exponential decay and is used to model kidney function and hemodialysis machine function:
The isotopes 284Nh and 283Nh have half-lives of 0.90 and 0.12 seconds respectively. The remaining two isotopes have half-lives between 0.1 and 100 milliseconds: 282Nh has a half-life of 61 milliseconds, and 278Nh, the lightest known nihonium isotope, is also the shortest-lived, with a half-life of 2.0 milliseconds. This rapid increase in the half-lives near the closed neutron shell at N = 184 is seen in roentgenium, copernicium, and nihonium (elements 111 through 113), where each extra neutron so far multiplies the half-life by a factor of 5 to 20. The unknown isotopes in the gap between 278Nh and 282Nh are too heavy to be produced by cold fusion and too light to be produced by hot fusion. The missing 280Nh and 281Nh may be populated as daughters of 284Mc and 285Mc, producible in the 241Am+48Ca reaction, but this has not yet been attempted. Of particular interest is 281Nh, as it is the expected great-granddaughter of 293119, a possible product of the 243Am+54Cr reaction. Production of 282Mc and 283Mc is possible in the 243Am+44Ca reaction (though it has a lower cross-section), and their daughters would be 278Nh (known) and 279Nh. The heavier isotopes 287Nh through 290Nh might be synthesised using charged-particle evaporation, using the 242Pu+48Ca and 244Pu+48Ca reactions where one proton and some neutrons are evaporated.
=== Cold War === The GIUK gap again became the focus of naval planning in the 1950s, as it represented the only available outlet into the Atlantic Ocean for Soviet submarines operating from their bases on the Kola Peninsula. NATO worried that if the Cold War "turned hot", naval convoys reinforcing Europe from the U.S. would suffer unacceptable losses if Soviet submarines could operate in the North Atlantic. The United States and the United Kingdom based much of their post-war naval strategy on blocking the gap, installing a chain of underwater listening posts right across it during the 1950s – an example of a SOSUS "sound surveillance system". This deployment of sonar surveillance in the gap, and elsewhere, hampered the Soviet Northern Fleet's ability to deploy its submarines without detection. The Royal Navy's primary mission during the Cold War, excluding its nuclear deterrent role, involved anti-submarine warfare (ASW). The development of the Invincible-class ASW aircraft carriers stemmed from this doctrine: their primary mission involved anti-submarine warfare using Sea King helicopters. The Type 23 frigate originated as a pure ASW platform; its mission expanded following the Falklands War of 1982. The largest Russian submarine drills through the GIUK gap were operations Aport and Atrina, in 1985 and 1987, respectively, when the Soviets deployed several nuclear-powered general-purpose attack submarines (SSNs) near the U.S. coast before the 1985 Gorbachev–Reagan meeting.
Facilitated diffusion is the passage of molecules or ions across a biological membrane through specific transport proteins and requires no energy input. Facilitated diffusion is used especially in the case of large polar molecules and charged ions; once such ions are dissolved in water they cannot diffuse freely across cell membranes due to the hydrophobic nature of the fatty acid tails of the phospholipids that make up the bilayers. The type of carrier proteins used in facilitated diffusion is slightly different from those used in active transport. They are still transmembrane carrier proteins, but these are gated transmembrane channels, meaning they do not internally translocate, nor require ATP to function. The substrate is taken in one side of the gated carrier, and without using ATP the substrate is released into the cell. Facilitated diffusion does not require the use of ATP as facilitated diffusion, like simple diffusion, transports molecules or ions along their concentration gradient.
===== Chain of any number of decays ===== For the general case of any number of consecutive decays in a decay chain, i.e. A1 → A2 ··· → Ai ··· → AD, where D is the number of decays and i is a dummy index (i = 1, 2, 3, ..., D), each nuclide population can be found in terms of the previous population. In this case N2 = 0, N3 = 0, ..., ND = 0. Using the above result in a recursive form:
Sources: en.wikipedia.org
CH2=CH2 + 3 O2 → 2 CO2 + 2 H2O, ΔH=−1327 kJ/mol (CH2CH2)O + 2.5 O2 → 2 CO2 + 2 H2O, ΔH=−1223 kJ/mol According to a kinetic analysis by Kilty and Sachtler, the following reactions describe the pathway leading to EO. In the first step, a superoxide (O2−) species is formed:
The Ames test, basically, is considered positive if a substance increases chance of mutation in the DNA of the bacteria enough to cause a quantifiable difference in the revertants of the mutagen plate and the control group plate. Negative Ames test means the possible mutagen DID not cause increase in revertants and positive Ames test signifies that the possible mutagen DID increase the chance of mutation. These mutagenic effects on bacteria are researched as a possible indicator of the same effects on larger organisms, like humans. It is suggested that if a mutation can arise in bacterial DNA under presence of a mutagen then the same effect would occur for larger organisms causing cancer. A negative Ames test result could suggest that the substance is not a mutagen and would not cause tumor formation in living organisms. However only few of the positive Ames Test resulting chemicals were considered insignificant when tested in larger organisms but the positive Ames test for bacteria still could not be conclusively linked to expression of cancer in larger organisms. While it can be a possible determinant of tumors for living organisms, humans, animals, and so on, more studies must be completed to come to a conclusion.
Many Irish nationalists sympathised with the Boers as oppressed by British imperialism, much like they viewed themselves. Irish miners already in the Transvaal at the start of the war formed the nucleus of two Irish commandos. The Second Irish Brigade was headed by an Australian of Irish parents, Colonel Arthur Lynch. Groups of Irish volunteers went to fight with the Boers—despite the fact that there were many Irish troops fighting in the British army, including the Royal Dublin Fusiliers. In Britain, the "Pro-Boer" campaign expanded, with writers often idealising the Boer society. The war highlighted the dangers of Britain's policy of non-alignment and deepened her isolation. The 1900 UK general election, also known as the "Khaki election", was called by the Prime Minister, Lord Salisbury, on the back of British victories. There was much enthusiasm for the war at this point, resulting in a victory for the Conservative government. However, support waned as it became apparent the war would not be easy and it dragged on, partially contributing to the Conservatives' spectacular defeat in 1906. There was outrage at scorched earth tactics and conditions in the concentration camps. It became apparent there were serious problems with public health in Britain as up to 40% of recruits in Britain were unfit for conscription, and suffered from medical problems such as rickets and other poverty-related illnesses. This came at a time of increasing concern for the poor in Britain. 22,000 Empire troops were killed.
== Function == BMPs interact with specific receptors on the cell surface, referred to as bone morphogenetic protein receptors (BMPRs). Signal transduction through BMPRs results in mobilization of members of the SMAD family of proteins. The signaling pathways involving BMPs, BMPRs and SMADs are important in the development of the heart, central nervous system, and cartilage, as well as post-natal bone development. They have an important role during embryonic development on the embryonic patterning and early skeletal formation. As such, disruption of BMP signaling can affect the body plan of the developing embryo. For example, BMP4 and its inhibitors noggin and chordin help regulate polarity of the embryo (i.e. back to front patterning). Specifically BMP-4 and its inhibitors play a major role in neurulation and the development of the neural plate. BMP-4 signals ectoderm cells to develop into skin cells, but the secretion of inhibitors by the underlying mesoderm blocks the action of BMP-4 to allow the ectoderm to continue on its normal course of neural cell development. Additionally, secretion of BMPs by the roof plate in the developing spinal cord helps to specify dorsal sensory interneurons. As a member of the transforming growth factor-beta superfamily, BMP signaling regulates a variety of embryonic patterning during fetal and embryonic development. For example, BMP signaling controls the early formation of the Müllerian duct (MD) which is a tubular structure in early embryonic developmental stage and eventually becomes female reproductive tracts.
Sources: en.wikipedia.org
Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.
Authorization is limited to a small number of countries and covers specific indications such as chronic hepatitis B and vaccine adjuvant use. Availability and labelling differ by jurisdiction.
Most reviews describe it as an immunomodulatory agent with an uncertain clinical effect. They generally call for larger, better-controlled trials before firm conclusions are drawn.
Cold storage slows the chemical degradation reactions that occur in solution. Lyophilized powder is more stable than reconstituted liquid and tolerates longer storage periods. Repeated temperature cycling should still be avoided because it can drive aggregation and loss of material.